AI-backed remote monitoring and digital therapeutics company Biofourmis confirmed the company's cofounder Kuldeep Singh Rajput stepped down as its CEO just one month after the company laid off 120 employees worldwide, 48 of whom were in the U.S.
"He remains committed to providing support and advice to the company going forward," Biofourmis told MobiHealthNews in an email. "We thank Kuldeep for...
AI-backed remote monitoring and digital therapeutics company Biofourmis confirmed it laid off 120 employees worldwide, including 48 workers in the U.S.
The Boston-based company offers home care tools to help remotely monitor acute and post-acute patients, then alter a care team when a patient's condition changes from their personal baseline.
It also offers digital therapies, including a heart-...
It's still early days for integrating digital therapeutics into clinical care, said panelists at the 2023 HIMSS Global Health Conference & Exhibition. But they have a role to play when developers consider the different needs of all healthcare stakeholders, including patients, hospitals, clinicians and payers.
Santosh Mohan, vice president of digital at Moffitt Cancer Center, said there are...
Australian startup Mindset Health has scooped up $12 million in a Series A funding round led by King River Capital. The round was also joined by Tenmile, Yard Ventures, WordPress founder Matt Mullenweg, Linktree founders Anthony Zaccaria and Nick Humphreys, and Banana Capital, among others.
Launched in 2018, the company develops a range of hypnosis-based DTx apps which address health conditions...
Prescription digital therapeutics company Pear Therapeutics is exploring "strategic alternatives," including a possible company sale, merger or acquisition.
In a press release, the company said it hired a financial advisor to look into actions that could "maximize shareholder value." That includes a potential sale, M&A, divestiture of assets, licensing or other strategic transactions. It may...
Akili Interactive, the company behind a video game-like prescription digital therapeutic for children with ADHD, reported its first full-year earnings since going public last year.
The company reported $323,000 in revenue for 2022 compared with $538,000 for 2021. Akili said 2022 revenue was entirely made up of funds earned from sales of EndeavorRx, its therapeutic that received FDA clearance for...
At the tail end of 2022, Click Therapeutics announced it was expanding its partnership with Boehringer Ingelheim focused on developing prescription digital therapeutics for patients with schizophrenia.
Pharma partnerships aren't new for digital health players, or for Click, which has several products in its development pipeline. The company's chief strategy officer, Austin Speier, said Click...
Pharma company Boehringer Ingelheim and Click Therapeutics announced an expanded partnership to develop and commercialize another prescription digital therapeutic for patients with schizophrenia.
The deal will net Click up to $460 million, plus tiered royalties. It builds on an earlier collaboration announced in 2020 that developed CT-155, an initial therapeutic for schizophrenia.
The companies...
Akili Interactive hit the public markets in August, bringing in cash the company will use to launch its video game digital therapeutic for children with ADHD later this year.
Akili's product, dubbed EndeavorRx, is prescription software for kids ages 8 to 12 who have attention issues. It received FDA De Novo clearance in 2020 after years waiting for the agency green light, though a nonprescription...
Theranica, an Israeli prescription digital therapeutics developer focused on migraine care, announced today that it has scored $45 million in Series C funding.
The round was led by New Rhein Healthcare Investors with participation from aMoon, Lightspeed Venture Partners, LionBird, Takoa Invest and Corundum Open Innovation.
The startup announced a $35 million Series B round of funding in 2019 and...
_1e92b.jpg "A woman holding a smartphone looking out a window.")
